BRIEF-Bowman To Acquire Exeltech, Expanding Bridge Design And Transportation Engineering-February 2024-www.financetom.com

BRIEF-Bowman To Acquire Exeltech, Expanding Bridge Design And Transportation Engineering

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Bowman To Acquire Exeltech, Expanding Bridge Design And Transportation Engineering

Nov 4, 2024 11:49 AM

Oct 31 (Reuters) - Bowman Consulting Group Ltd ( BWMN ):

* BOWMAN TO ACQUIRE EXELTECH, EXPANDING BRIDGE DESIGN AND

TRANSPORTATION ENGINEERING

* BOWMAN CONSULTING GROUP LTD ( BWMN ) - ACQUISITION FINANCED WITH

CASH,

NOTES, AND CONVERTIBLE NOTE AT $32.32 PER SHARE

Source text:

Further company coverage:

Previous page： TransMedics Shares Drop After Short Report From Scorpion Capital Next page： Vizsla Silver Reports Employee Fatality at Panuco Project in Mexico

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

TransMedics Shares Drop After Short Report From Scorpion Capital

Jan 10, 2025

10:12 AM EST, 01/10/2025 (MT Newswires) -- TransMedics Group ( TMDX ) shares were down almost 15% in recent Friday trading following a short seller report by Scorpion Capital, which called the company an organ trafficking scheme masquerading as a medical device company. Scorpion Capital said in its report that the scheme is powered by kickbacks, billing fraud, unreported device...

Vizsla Silver Reports Employee Fatality at Panuco Project in Mexico

Jan 10, 2025

10:11 AM EST, 01/10/2025 (MT Newswires) -- Vizsla Silver ( VZLA ) on Friday announced that a landslide at the Panuco project in Sinaloa, Mexico, impacted an exploration drill pad and killed an employee of a contractor, Bysla Drilling. A second employee of Bylsa was also injured in the same incident and is currently in hospital in critical condition. Vizsla...

Pacira Biosciences Reports Preliminary 2024 Revenue Rose, Outlines Five-Year Plan

Jan 10, 2025

10:14 AM EST, 01/10/2025 (MT Newswires) -- Pacira Biosciences ( PCRX ) reported preliminary 2024 revenue Friday of $701 million, up from $675 million a year earlier. Analysts polled by FactSet expect $695.1 million. The company also outlined a five-year strategy to expand its focus on musculoskeletal pain and related areas, aiming for growth by 2030. The plan, called 5x30,...

Update: BlackRock Asks US FDIC to Extend Deadline on Oversight Agreement

Jan 10, 2025

10:12 AM EST, 01/10/2025 (MT Newswires) -- (Updates with the US FDIC's response in the fourth paragraph and latest stock movement in the fifth paragraph.) BlackRock ( BLK ) has made a request to the US Federal Deposit Insurance Corporation to extend a deadline for a new oversight agreement relating to its stakes in FDIC-regulated banks, media reports said Friday....